Prevalence Rate of Pulmonary Embolism Among Not Anticoagulated Patients
NCT ID: NCT03525535
Last Updated: 2019-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1 participants
OBSERVATIONAL
2018-06-14
2018-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of Intensive Medical Follow-up with an Advanced Practice Nurse Compared with Medical Follow-up Alone in Non-severe Pulmonary Embolism.
NCT06598930
Prevalence of Pulmonary Embolism in Patients With Syncope
NCT01797289
Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event
NCT05073666
Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT02035293
Data Clustering Study With Artificial Intelligence and Phenotyping of Patients With Acute Pulmonary Embolism
NCT06183944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data collected will come from the routine care such as medical history, clinical datas, imaging data… The number of pulmonary imaging will be assessed before the diagnostic strategy proposed by Dr Prandoni and after the application of this strategy thanks to a questionnaire to physicians.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary embolism
data from routine care will be collected for patient eligible and willing to participate
data collection
data from patient included will be collected during the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
data from patient included will be collected during the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Emergency consult resulting on an hospitalization in the geriatric service or in the internal medicine service
* Hospitalised in the Centre Hospitalier Intercommunal de Toulon for syncope, presenting these symptoms:
* Loss of consciousness with quick return to normal (less than one minute)
* Spontaneous resolution
Exclusion Criteria
* other loss of consciousness (epilepsy, stroke, head trauma)
* anticoagulated treatment
* patient's objection
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoit Faucher, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
La Seyne-sur-Mer, Var, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01197-46
Identifier Type: OTHER
Identifier Source: secondary_id
2017-CHITS-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.